Artizan Biosciences
New York
About Artizan Biosciences
Artizan Biosciences provides pharmaceutical drug development services, namely, the development of small molecule drugs for use in humans. The Durham-based biotech company declined to disclose its intended use of the proceeds from this offering, as well as its current revenue range.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $35.4M
- Last round: Series Unknown (Nov 2025)
- Website: artizanbiosciences.com
Industries & Categories
Biopharma, Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/artizan-biosciences-21691 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.